针和埃斯基塔洛普拉姆治疗严重抑郁症的临床研究 (AE-TMDCS):一个因子随机对照试验的协议
Kaiqi Yang1, Sagun Tiwari2, Dezhi Liu3
1Department of Neurology and Rehabilitation, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
BMJ open
|September 11, 2024
概括
这项研究将针与埃斯基塔洛普拉姆 (escitalopram) 进行比较,用于治疗严重抑郁症 (MDD). 它调查了针是否为抑郁症管理提供了可行的替代或辅助疗法.
科学领域:
- 综合医学是一个整体的医学.
- 临床精神病学 临床精神病学
- 神经科学是一个神经科学.
背景情况:
- 大型抑郁症 (MDD) 是全球导致残疾的主要原因,严重影响生活质量,并产生巨大的经济成本.
- 虽然针对MDD治疗有希望,但对标准抗抑郁药物缺乏严格的比较证据.
- 这项研究解决了关于针治疗抑郁症治疗疗效的可靠数据的需求.
研究的目的:
- 在中度至重度MDD患者中,比较针与抗抑郁药物埃斯基塔洛普拉姆的治疗疗效.
- 评估针作为潜在的独立或辅助治疗抑郁症.
- 为MDD管理中的临床决策提供高质量的证据.
主要方法:
- 一个多中心的,随机的,参与者盲目的,假控制的,2×2因子试验,涉及260名中度至重度MDD患者.
- 参与者被分配到四个组之一:针/,假针/,针/安慰剂,或假针/安慰剂.
- 治疗包括10周的30次会议,主要结果是汉密尔顿抑郁症评分表 (HDRS-17) 评分的变化.
主要成果:
- 这项研究旨在严格比较针和埃斯基塔洛普拉姆的疗效.
- 它将分析HDRS-17分数的变化作为主要结果.
- 二次结果包括使用各种验证的尺度对抑郁,焦虑和认知功能的评估.
结论:
- 这些发现将阐明针和埃斯基塔洛普拉姆对MDD的比较有效性.
- 本研究旨在为抑郁症治疗提供基于证据的指导方针.
- 结果将有助于理解针在整合性精神卫生保健中的作用.
相关概念视频
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K